Clinical Trial Update: Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial evaluating the safety, tolerability, and potential efficacy of YM150 in patients with Acute Coronary Syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• YM150

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED